cerdulatinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cerdulatinib, covering 2023-02-21 to 2023-02-21. Get the full timeline:
Most recent: Clinical Trial Update: CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) [Phase 2, Phase 3]